Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
KLG - WK Kellogg Co - Stock Price Chart
TickerKLG [NYSE]
CompanyWK Kellogg Co
CountryUSA
IndustryPackaged Foods
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume4.99M52W Range13.75 - 21.00
TodayInitiated Goldman Sell $11
TodayInitiated Exane BNP Paribas Neutral $14
Today 07:32AM WK KELLOGG CO CELEBRATES LAUNCH AS AN INDEPENDENT COMPANY (PR Newswire)
Oct-02-23 04:27PM Instacart stock falls, Nvidia rises on 'Conviction Buy': Trending Tickers (Yahoo Finance Video) -9.06%
04:12PM Kellanova, WK Kellogg Stocks Finish Their First Trading Day Lower (The Wall Street Journal)
11:53AM Kellanova CEO on Kellogg's split: 'Our innovation pipeline is robust' (Yahoo Finance Video)
10:03AM Rivian upgraded, SolarEdge downgraded: Wall Street's top analyst calls (The Fly)
09:27AM Kellogg stock slides as iconic company prepares to break up (Yahoo Finance)
09:27AM Kellogg stock slides as iconic company breaks up (Yahoo Finance)
AXDX - Accelerate Diagnostics Inc - Stock Price Chart
TickerAXDX [NASD]
CompanyAccelerate Diagnostics Inc
CountryUSA
IndustryMedical Devices
Market Cap93.12MEPS (ttm)-8.01
P/E-EPS this Y6.84%
Forward P/E-EPS next Y54.97%
PEG-EPS past 5Y8.41%
P/S7.99EPS next 5Y30.00%
P/B-EPS Q/Q-22.37%
Dividend-Sales Q/Q-24.35%
Insider Own47.86%Inst Own15.60%
Insider Trans-0.87%Inst Trans-
Short Float4.71%EarningsAug 10/a
Analyst Recom2.00Target Price40.00
Avg Volume24.21K52W Range4.50 - 17.80
Sep-14-23 11:01PM Insider Sell: CEO Jack Phillips Sells 733 Shares of Accelerate Diagnostics Inc (GuruFocus.com)
Aug-11-23 05:59AM Q2 2023 Accelerate Diagnostics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-10-23 05:30PM Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:26PM Accelerate Diagnostics: Q2 Earnings Snapshot (AP Finance)
04:05PM Accelerate Diagnostics Reports Second Quarter 2023 Financial Results (PR Newswire)
Jul-27-23 09:30AM Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results (PR Newswire)
Jul-10-23 09:00AM Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split (PR Newswire) -6.29%
Jun-29-23 09:40AM Is Accelerate Diagnostics (AXDX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jun-13-23 09:40AM Is Akero Therapeutics (AKRO) Outperforming Other Medical Stocks This Year? (Zacks) -23.32%
09:00AM Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform Wave (PR Newswire)
BBAI - BigBear.ai Holdings Inc - Stock Price Chart
TickerBBAI [NYSE, RUT]
CompanyBigBear.ai Holdings Inc
CountryUSA
IndustryInformation Technology Services
Market Cap218.16MEPS (ttm)-0.69
P/E-EPS this Y65.53%
Forward P/E-EPS next Y38.93%
PEG-EPS past 5Y-
P/S1.35EPS next 5Y-
P/B-EPS Q/Q74.22%
Dividend-Sales Q/Q2.25%
Insider Own68.93%Inst Own10.96%
Insider Trans-9.18%Inst Trans-28.41%
Short Float14.19%EarningsAug 08/a
Analyst Recom2.20Target Price3.67
Avg Volume3.24M52W Range0.58 - 6.77
Sep-04-23 07:54PM These 2 AI Stocks Under $5 Have Triple-Digit Upside Potential, Says Analyst (TipRanks)
Aug-29-23 09:37AM Oracle upgraded, Farfetch downgraded: Wall Street's top analyst calls (The Fly) +17.52%
Aug-08-23 04:15PM BigBear.ai Announces Second Quarter 2023 Financial Results (Business Wire)
Jul-25-23 04:15PM BigBear.ai to Report Second Quarter 2023 Results on August 8, 2023 (Business Wire)
Jun-12-23 08:00AM BigBear.ai Receives 6-Month, $8.5M Extension on Phase 2 of U.S. Army GFIM OTA, Successfully Completes User Acceptance Training with U.S. Army (Business Wire)
Jun-08-23 11:24PM BigBear.ai Announces Registered Direct Offering of Common Stock and Warrants (Business Wire)
May-09-23 04:15PM BigBear.ai Announces 16% Year-over-Year Revenue Growth in First Quarter 2023 and Reporting Segment Changes (Business Wire) +6.45%
Apr-25-23 04:15PM BigBear.ai to Report First Quarter 2023 Results on May 9, 2023 (Business Wire)
Apr-08-23 06:00AM 3 things you may have missed in markets amid weak economic data (Yahoo Finance)
Apr-06-23 08:32AM Why speculative AI stocks like C3.ai and BigBear.ai are seeing monster volatility (Yahoo Finance) +14.09%
ELDN - Eledon Pharmaceuticals Inc - Stock Price Chart
TickerELDN [NASD]
CompanyEledon Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap34.89MEPS (ttm)-6.12
P/E-EPS this Y68.91%
Forward P/E-EPS next Y25.77%
PEG-EPS past 5Y31.69%
P/S-EPS next 5Y-
P/B0.36EPS Q/Q38.44%
Dividend-Sales Q/Q-
Insider Own6.01%Inst Own42.08%
Insider Trans0.00%Inst Trans-2.38%
Short Float0.15%EarningsAug 10/b
Analyst Recom1.00Target Price14.80
Avg Volume64.94K52W Range1.08 - 3.70
Oct-02-23 07:00AM Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors (GlobeNewswire) +13.14%
Sep-25-23 07:00AM Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human (GlobeNewswire)
Sep-20-23 04:05PM Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Sep-11-23 07:00AM Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors (GlobeNewswire)
Sep-06-23 07:00AM Eledon Pharmaceuticals Announces Publication of Data Showing Treatment with Tegoprubart Promotes Kidney and Islet Allograft Survival and Function in Nonhuman Primates (GlobeNewswire) -11.89%
Sep-05-23 07:00AM Eledon Pharmaceuticals Announces First Participant Dosed in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Rejection in Kidney Transplantation (GlobeNewswire)
Aug-16-23 07:00AM Eledon Pharmaceuticals Announces Dosing of 10th Patient in Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation (GlobeNewswire)
Aug-10-23 07:00AM Eledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results (GlobeNewswire)
Jul-12-23 07:30AM Amerigo Reports Q2-2023 Production Results and Provides MVC Operational Update (GlobeNewswire)
Jun-02-23 08:00AM Eledon Pharmaceuticals to Present at Jefferies Healthcare Conference (GlobeNewswire)
FNGR - FingerMotion Inc - Stock Price Chart
TickerFNGR [NASD]
CompanyFingerMotion Inc
CountrySingapore
IndustryTelecom Services
Market Cap363.93MEPS (ttm)-0.16
P/E-EPS this Y70.59%
Forward P/E233.33EPS next Y-
PEG-EPS past 5Y-2.69%
P/S8.80EPS next 5Y-
P/B26.04EPS Q/Q27.22%
Dividend-Sales Q/Q150.64%
Insider Own48.57%Inst Own1.29%
Insider Trans9.31%Inst Trans-7.08%
Short Float5.76%Earnings-
Analyst Recom1.00Target Price5.00
Avg Volume955.68K52W Range1.01 - 9.80
Oct-02-23 05:01PM FingerMotion (FNGR) Stock Pops as Shelf Offering Takes Effect (InvestorPlace) +12.72%
Jul-25-23 08:00AM Martin J. Shen, CEO FingerMotion Inc. Discusses Company Progress and Future Plans with Steve Macalbry of BestGrowthStocks.Com (News Direct) +10.87%
Jul-14-23 09:00AM FingerMotion Reports Q1 2024 Financial Results (ACCESSWIRE) -5.32%
Jun-05-23 09:45AM FingerMotion to Present at the LD Micro Invitational XIII Conference in Los Angeles on June 6-8, 2023 (ACCESSWIRE)
May-30-23 04:35PM FingerMotion Reports FY 2023 Financial Results (GlobeNewswire) +13.91%
May-12-23 09:30AM FingerMotion Enters into Cooperation Agreement Seeking to Expand into Overseas Hardware and Terminal Business with Migu Video Technology Co. Ltd. (GlobeNewswire) -7.36%
Apr-24-23 09:00AM Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-12-23 09:00AM FingerMotion Retires Convertible Debt Totaling Over $5 Million, Eliminating all Institutional Loans (ACCESSWIRE) -9.83%
Feb-21-23 10:00AM Creatd Welcomes Martin Shen of FingerMotion (NASDAQ:FNGR) as Member of CEOBLOC Advisory Board (PR Newswire) -13.99%
09:00AM FingerMotion Announces Results of Annual Meeting (ACCESSWIRE)
OPAD - Offerpad Solutions Inc - Stock Price Chart
TickerOPAD [NYSE]
CompanyOfferpad Solutions Inc
CountryUSA
IndustryReal Estate Services
Market Cap225.46MEPS (ttm)-1.80
P/E-EPS this Y60.54%
Forward P/E-EPS next Y57.01%
PEG-EPS past 5Y-
P/S0.10EPS next 5Y-
P/B1.69EPS Q/Q-
Dividend-Sales Q/Q-78.68%
Insider Own61.38%Inst Own13.19%
Insider Trans0.54%Inst Trans-24.48%
Short Float7.79%EarningsAug 02/b
Analyst Recom2.71Target Price8.38
Avg Volume72.78K52W Range5.63 - 19.35
Aug-23-23 04:05PM Offerpad Announces Participation in Goldman Sachs Communacopia + Technology Conference (Business Wire) +5.54%
Aug-02-23 08:45AM Offerpad Reports Second Quarter 2023 Results (Business Wire)
Jul-26-23 10:45AM Offerpads Agent Partnership Program: 3 Years of 3% to Real Estate Agents (Business Wire)
Jul-06-23 06:30AM Veteran Finance and Tech Executive with Track Record of Driving Transformational Change Joins Offerpad (Business Wire) -7.14%
Jun-29-23 04:30PM Offerpad to Release Second-Quarter Results on August 2nd (Business Wire)
Jun-20-23 04:46PM Offerpads Simple Real Estate Solutions Drive Greater Customer Satisfaction During Heightened Market Uncertainty (Business Wire)
Jun-08-23 04:10PM Offerpad Announces Reverse Stock Split (Business Wire) +10.92%
May-03-23 04:10PM Offerpad Reports First Quarter 2023 Results (Business Wire)
Apr-06-23 05:00PM Offerpad to Release First-Quarter Results on May 3rd (Business Wire)
Feb-23-23 08:30AM Offerpad to Present at Upcoming Investor Conference (Business Wire) -6.12%
PTN - Palatin Technologies Inc. - Stock Price Chart
TickerPTN [AMEX]
CompanyPalatin Technologies Inc.
CountryUSA
IndustryBiotechnology
Market Cap19.70MEPS (ttm)-2.53
P/E-EPS this Y30.04%
Forward P/E-EPS next Y72.88%
PEG-EPS past 5Y-
P/S4.06EPS next 5Y-
P/B148.70EPS Q/Q31.69%
Dividend-Sales Q/Q128.60%
Insider Own8.70%Inst Own7.63%
Insider Trans0.00%Inst Trans14.22%
Short Float4.19%EarningsSep 28/b
Analyst Recom1.00Target Price83.33
Avg Volume93.09K52W Range1.43 - 6.40
Today 08:35AM Palatin Technologies, Inc. (AMEX:PTN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Sep-29-23 01:34AM Q4 2023 Palatin Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Sep-28-23 07:30AM Palatin Reports Fourth Quarter and Fiscal Year Ended 2023 Financial Results and Provides Corporate Update (PR Newswire) -9.09%
Sep-22-23 04:00PM Palatin to Report Fourth Quarter and Fiscal Year End 2023 Results; Teleconference and Webcast to be held on September 28, 2023 (PR Newswire) -5.66%
Sep-07-23 04:00PM Palatin to Present at the H.C. Wainwright 25th Annual Global Investment Conference (PR Newswire)
07:30AM Palatin Completes Enrollment in Phase 3 MELODY-1 Study of PL9643 For the Treatment of Patients with Dry Eye Disease (PR Newswire)
Aug-10-23 07:30AM Palatin Initiates Clinical Program for Bremelanotide Co-Formulated with a PDE5i for the Treatment of ED in Patients Non-Responsive to PDE5i Treatment (PR Newswire) -5.50%
Aug-08-23 07:30AM Palatin's Vyleesi® Licensee Fosun Pharma Reports First Commercial Sale in China and South Korean Licensee Kwangdong Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study (PR Newswire) +8.20%
Aug-07-23 07:30AM Palatin Announces Direct-to-Consumer Telehealth Partnership with UpScriptHealth for Vyleesi® (PR Newswire) +23.86%
Aug-04-23 07:30AM Palatin to Participate in Canaccord Genuity's 43rd Annual Growth Conference (PR Newswire)
NAMS - NewAmsterdam Pharma Company NV - Stock Price Chart
TickerNAMS [NASD]
CompanyNewAmsterdam Pharma Company NV
CountryNetherlands
IndustryBiotechnology
Market Cap693.13MEPS (ttm)-0.20
P/E-EPS this Y-77.09%
Forward P/E-EPS next Y24.95%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.50EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own59.38%Inst Own26.83%
Insider Trans0.00%Inst Trans3.58%
Short Float0.98%EarningsAug 07/b
Analyst Recom1.00Target Price24.37
Avg Volume106.03K52W Range7.52 - 32.88
Sep-21-23 07:00AM NewAmsterdam Pharma Announces Initial Data from Phase 2a Clinical Trial Evaluating Obicetrapib in Patients with Early Alzheimers Disease Who Carry an ApoE4 Mutation (GlobeNewswire)
Sep-20-23 08:00AM NewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Aug-14-23 04:01PM NewAmsterdam Pharma Announces Appointment of William BJ Jones, formerly of Biohaven Pharmaceuticals, as Chief Commercial Officer (GlobeNewswire)
Aug-10-23 06:01AM NewAmsterdam Pharma First Half 2023 Earnings: 0.92 loss per share (vs 1.50 profit in 1H 2022) (Simply Wall St.)
Aug-07-23 07:15AM NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter 2023 Financial Highlights (GlobeNewswire)
Jul-25-23 04:01PM NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia and/or Established Atherosclerotic Cardiovascular Disease (GlobeNewswire)
Jun-09-23 04:01PM NewAmsterdam Pharma Announces Closing of Upsized Secondary Offering of Ordinary Shares (GlobeNewswire)
Jun-06-23 11:25PM NewAmsterdam Pharma Announces Pricing of Upsized Secondary Offering of Ordinary Shares (GlobeNewswire)
04:01PM NewAmsterdam Pharma Announces Commencement of Secondary Offering of Ordinary Shares (GlobeNewswire)
Jun-05-23 07:00AM NewAmsterdam Pharma Announces Positive Topline Results from Phase 2b Dose-Finding Trial Evaluating Obicetrapib in Japanese Patients (GlobeNewswire)
FRLN - Freeline Therapeutics Holdings plc ADR - Stock Price Chart
TickerFRLN [NASD]
CompanyFreeline Therapeutics Holdings plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap16.61MEPS (ttm)-12.16
P/E-EPS this Y95.71%
Forward P/E-EPS next Y1.60%
PEG-EPS past 5Y-
P/S26.79EPS next 5Y-
P/B0.40EPS Q/Q33.85%
Dividend-Sales Q/Q-
Insider Own4.96%Inst Own53.82%
Insider Trans0.00%Inst Trans-1.70%
Short Float2.49%EarningsAug 15/b
Analyst Recom1.50Target Price9.50
Avg Volume363.70K52W Range2.11 - 12.00
Aug-17-23 07:04AM Freeline Therapeutics Holdings plc (NASDAQ:FRLN) Q2 2023 Earnings Call Transcript (Insider Monkey) +9.21%
Aug-16-23 12:39AM Q2 2023 Freeline Therapeutics Holdings PLC Earnings Call (Thomson Reuters StreetEvents)
Aug-15-23 07:00AM Freeline Reports Second Quarter 2023 Financial Results and Business Highlights (GlobeNewswire) -5.85%
Aug-08-23 07:30AM Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call (GlobeNewswire)
Jul-31-23 07:30AM Freeline to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-25-23 07:30AM Freeline to Host Virtual KOL Event on its Gene Therapy Candidate, FLT201, in Gaucher Disease (GlobeNewswire) -5.57%
Jul-13-23 08:09AM Estimating The Fair Value Of Freeline Therapeutics Holdings plc (NASDAQ:FRLN) (Simply Wall St.) -17.39%
Jun-26-23 07:30AM Freeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinsons Disease (GlobeNewswire)
Jun-13-23 09:55AM Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks) +10.30%
Jun-02-23 08:00AM Freeline to Present at 2023 Jefferies Healthcare Conference (GlobeNewswire)
DYN - Dyne Therapeutics Inc - Stock Price Chart
TickerDYN [NASD, RUT]
CompanyDyne Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap484.50MEPS (ttm)-3.41
P/E-EPS this Y-7.43%
Forward P/E-EPS next Y10.09%
PEG-EPS past 5Y-135.08%
P/S-EPS next 5Y-
P/B2.34EPS Q/Q-7.17%
Dividend-Sales Q/Q-
Insider Own47.06%Inst Own61.40%
Insider Trans-1.43%Inst Trans-4.54%
Short Float17.02%EarningsAug 03/b
Analyst Recom1.00Target Price29.38
Avg Volume420.67K52W Range8.04 - 15.60
Sep-28-23 07:30AM Dyne Therapeutics to Present at October Investor Conferences (GlobeNewswire)
Sep-20-23 04:05PM Dyne Therapeutics Receives FDA Orphan Drug Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1 (GlobeNewswire) -5.48%
Sep-15-23 01:52PM Why Shares of Dyne Therapeutics Fell This Week (Motley Fool)
Sep-14-23 01:22PM Insider Sell: Chief Medical Officer Wildon Farwell Sells 1,707 Shares of Dyne Therapeutics Inc (GuruFocus.com)
Sep-05-23 07:30AM Dyne Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference (GlobeNewswire)
Aug-28-23 10:22AM 15 Most Shorted Stocks That Are Loved By Analysts (Insider Monkey)
Aug-03-23 07:30AM Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights (GlobeNewswire)
Jun-16-23 08:46AM SMID Caps Are Poised for a Good Run, Says Oppenheimer And These 2 Stocks Fit the Bill With Over 100% Upside (TipRanks) -9.50%
Jun-01-23 07:30AM Dyne Therapeutics to Present at Jefferies Healthcare Conference (GlobeNewswire)
May-25-23 07:30AM Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101 (GlobeNewswire) -7.56%
1⋯56789101112131415⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2023 FINVIZ.com. All Rights Reserved.